Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerOpenAI sign Language
VIPCreated with Sketch.

Advances in 211At production at Texas A&M University

S.J. Yennello,L.A McIntosh,J.D. Burns,E.E. Tereshatov,G. Tabacaru,L. McCann,S. Schultz, K. Lofton,A. Abbott, G. Avila, M. Berko, E. Engelthaler,K. Hagel,A. Hannaman,B. Harvey,A. Hood, M. McCarthy,A.B. McIntosh,M. Sorensen,Z Tobin, A. Vonder Haar

EPJ Web of Conferences（2021）

Cited 5|Views0
No score
Abstract
Alpha emitting radionuclides with medically relevant half-lives are interesting for treatment of tumors and other diseases because they deposit large amounts of energy close to the location of the radioisotope. Researchers at the Cyclotron Institute at Texas A&M University are developing a program to produce 211At, an alpha emitter with a medically relevant half-life. The properties of 211At make it a great candidate for targeted alpha therapy for cancer due to its short half-life (7.2 h). Astatine-211 has now been produced multiple times and reliability of this process is being improved.
More
Translated text
Key words
<sup>211</sup>at,university,advances,production,texas
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined